Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN News Highlights: Back to Item

BARDA Doles Out $215M in Influenza Vaccine Contracts

Novavax will receive $97 million and VaxInnate $117.9 million to advance next-generation recombinant candidates.



Click here to log in or to register for free.

You will be taken back to your selected item after log-in/registration.

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll